Clinical Trials Browser

Recruiting × INDUSTRY × zipalertinib × Clear all

NCT05967689 2026-03-10

REZILIENT2

Phase 2 Recruiting

Carcinoma, Lung Diseases

NCT07128199 2026-02-03

REZILIENT4

Phase 3 Recruiting

Carcinoma, Non-Small-Cell Lung, Lung Neoplasms